Cite
Seeber A, Gastl G, Ensinger C, et al. Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project. Genes Cancer. 2016;7(9):301-308doi: 10.18632/genesandcancer.121.
Seeber, A., Gastl, G., Ensinger, C., Spizzo, G., Willenbacher, W., Kocher, F., Leitner, C., Willenbacher, E., Amann, A., Steiner, N., Eisterer, W., Voss, A., Russell, K., & Zwierzina, H. (2016). Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project. Genes & cancer, 7(9), 301-308. https://doi.org/10.18632/genesandcancer.121
Seeber, Andreas, et al. "Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project." Genes & cancer vol. 7,9 (2016): 301-308. doi: https://doi.org/10.18632/genesandcancer.121
Seeber A, Gastl G, Ensinger C, Spizzo G, Willenbacher W, Kocher F, Leitner C, Willenbacher E, Amann A, Steiner N, Eisterer W, Voss A, Russell K, Zwierzina H. Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project. Genes Cancer. 2016 Sep;7(9):301-308. doi: 10.18632/genesandcancer.121. PMID: 28050231; PMCID: PMC5115171.
Copy
Download .nbib